Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
Global device networker role, regulatory agility and patient safety prioritized in new chapter for UK regulator
Executive Summary
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
You may also be interested in...
COVID-Delayed UK Medtech Mandate Previews First Products For NHS Adoption
The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.
Compare And Contrast: New UKCA Marking System Will Stress Safety, Quality And Agility
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.